JamesWilliamWelshMD

PubMed

• Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable local...
  Kelsey L Corrigan, Ting Xu, Yuki Sasaki, Ruitao Lin, Aileen B Chen, James W Welsh, Steven H Lin, Joe Y Chang, Matthew S Ning, Saumil Gandhi, Michael S O'Reilly, Carl M...> ;Radiotherapy and Oncology. 2024 Apr 1
• Hybridizing mechanistic mathematical modeling with deep learning methods to predict individual cancer patient survival after immune checkpoint inhibitor therapy.
  Prashant Dogra, Vittorio Cristini, Zhihui Wang, Joseph D Butner, Caroline Chung, Eugene J Koay, James W Welsh, David S Hong> ;Research Square. 2024 Mar 29
• Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy.
  Yun Hu, Alexey Revenko, Hampartsoum Barsoumian, Genevieve Bertolet, Natalie Wall Fowlkes, Hadi Maazi, Morgan Maureen Green, Kewen He, Duygu Sezen, Tiffany A Voss, Clau...> ;Journal of Experimental & Clinical Cancer Research. 2024 Mar 6
• The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC.
  Joanne B Weidhaas, Chen Hu, Ritsuko Komaki, Gregory A Masters, George R Blumenschein, Joe Y Chang, Bo Lu, Adam P Dicker, Jeffrey A Bogart, Yolanda I Garces, Samir Nara...> ;Cancer Research Communications. 2023 Oct 11
• 21 citations
  Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an op...
  Joe Y Chang, Steven H Lin, Wenli Dong, Zhongxing Liao, Saumil J Gandhi, Carl M Gay, Jianjun Zhang, Stephen G Chun, Yasir Y Elamin, Frank V Fossella, George Blumenschei...> ;Lancet. 2023 Sep 9
• 3 citations
  Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-r...
  Mehmet Altan, Yan Wang, Juhee Song, James Welsh, Chad Tang, Nandita Guha-Thakurta, George R Blumenschein, Brett W Carter, Jeffrey S Wefel, Amol J Ghia, Debra N Yeboa, ...> ;Journal for Immunotherapy of Cancer. 2023 Jul 1
• 4 citations
  Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection.
  Yun Hu, Sébastien Paris, Narayan Sahoo, Genevieve Bertolet, Qi Wang, Qianxia Wang, Hampartsoum B Barsoumian, Jordan Da Silva, Ailing Huang, Denaha J Doss, David P Poll...> ;JCI Insight. 2023 Jun 22
• 3 citations
  NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model.
  Hampartsoum B Barsoumian, Kewen He, Ethan Hsu, Genevieve Bertolet, Duygu Sezen, Yun Hu, Thomas S Riad, Maria Angelica Cortez, James W Welsh> ;Cancer Immunology, Immunotherapy. 2023 Sep 1
• 1 citations
  Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic disease.
  Kewen He, David S Hong, Chad Tang, Duygu Sezen, Livia Cox, Aurian Maleki, Genevieve Bertolet, Quynh-Nhu Nguyen, Nathan I Comeaux, Lily Schuda, Dawei Chen, James W Welsh> ;Radiotherapy and Oncology. 2023 Jun 1
• 1 citations
  NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model.
  Hampartsoum B Barsoumian, Kewen He, Ethan Hsu, Genevieve Bertolet, Duygu Sezen, Yun Hu, Maria Angelica Cortez, James W Welsh> ;Research Square. 2023 Feb 13
• 9 citations
  Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD-1 in Metastatic Non-Small Cell Lung Cancer.
  Kewen He, Hampartsoum B Barsoumian, Nahum Puebla-Osorio, Yun Hu, Duygu Sezen, Mark D Wasley, Genevieve Bertolet, Jie Zhang, Carola Leuschner, Liangpeng Yang, Claudia S...> ;Cancer Immunology Research. 2023 Apr 3
• Corrigendum: Lipid metabolism in tumor immunology and immunotherapy.
  Duong, L., Corbali, H., Riad, T., Ganjoo, S., Nanez, S., Voss, T., Barsoumian, H., Cortez, M., Welsh, J.> ;Frontiers in Oncology. 2023 Jan 1
• Updates on radiotherapy-immunotherapy combinations: Proceedings of 6annual ImmunoRad conference.
  Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, Nina Bhardwaj, Charleen Chan Wah Hak, Alba Fiorentino, Chandan Guha, Monica L Guzman, Kevin Harrington, Fern...> ;Oncoimmunology. 2023 Jan 1
• The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy.
  Shonik Ganjoo, Priti Gupta, Halil Ibrahim Corbali, Selene Nanez, Thomas S Riad, Lisa K Duong, Hampartsoum B Barsoumian, Fatemeh Masrorpour, Hong Jiang, James W Welsh, ...> ;Frontiers in Immunology. 2023 Jan 1
• Lipid metabolism in tumor immunology and immunotherapy.
  Lisa K Duong, Halil Ibrahim Corbali, Thomas S Riad, Shonik Ganjoo, Selene Nanez, Tiffany Voss, Hampartsum Barsomium, James Welsh, Maria Angelica Cortez> ;Frontiers in Oncology. 2023 Jan 1
• Radiation Therapy Modulates Tumor Physical Characteristics to Reduce Intratumoral Pressure and Enhance Intratumoral Drug Delivery and Retention.
  Hampartsoum B Barsoumian, Rahul A Sheth, Rishab Ramapriyan, Ethan Hsu, Mihai Gagea, Kaitlyn Crowley, Duygu Sezen, Malea Williams, James W Welsh> ;Advances in Radiation Oncology. 2022 Dec 5
• 11 citations
  Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer.
  Yun Hu, Sébastien Paris, Genevieve Bertolet, Hampartsoum B Barsoumian, Kewen He, Duygu Sezen, Dawei Chen, Mark Wasley, Jordan DA Silva, Joylise A Mitchell, Tiffany A V...> ;Journal of Nanobiotechnology. 2022 Sep 19
• 3 citations
  Local Therapy for Oligoprogressive Disease: A Systematic Review of Prospective Trials.
  Hans Kim, Bhanu P Venkatesulu, Matthew T McMillan, Vivek Verma, Steven H Lin, Joe Y Chang, James W Welsh> ;International Journal of Radiation Oncology, Biology, Physics. 2022 Nov 15
• 1 citations
  A Systematic Review of the Cost-Effectiveness of Stereotactic Radiation Therapy for Cancer Oligometastases.
  Vivek Verma, Nikhil Yegya-Raman, Tanja Sprave, Guang Han, Hagop M Kantarjian, James W Welsh, Joe Y Chang, Steven H Lin> ;International Journal of Radiation Oncology, Biology, Physics. 2022 Dec 1
• 3 citations
  Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC.
  Joe Y Chang, Vivek Verma, James W Welsh, Silvia C Formenti> ;The Lancet. Oncology. 2022 Apr 1
• 6 citations
  Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer.
  Waqar Haque, Anukriti Singh, Henry S Park, Bin S Teh, E Brian Butler, Ming Zeng, Steven H Lin, James W Welsh, Joe Y Chang, Vivek Verma> ;Acta Oncologica. 2022 Apr 1
• 16 citations
  High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses.
  Hampartsoum B Barsoumian, Duygu Sezen, Hari Menon, Ahmed I Younes, Yun Hu, Kewen He, Nahum Puebla-Osorio, Mark Wasley, Ethan Hsu, Roshal R Patel, Liangpeng Yang, Maria...> ;Cancers. 2022 Jan 3
• 9 citations
  Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical data.
  Ji Son, Rodney Cheng-En Hsieh, Heather Y Lin, Kate J Krause, Ying Yuan, Amadeo B Biter, James Welsh, Michael A Curran, David S Hong> ;Frontiers in Immunology. 2022 Jan 1
• 1 citations
  The potential of biology-guided radiation therapy in thoracic cancer: A preliminary treatment planning study.
  Steven N Seyedin, Rostem Bassalow, Osama R Mawlawi, Lehendrick M Turner, Roshal R Patel, Samuel R Mazin, Oluwaseyi M Oderinde, Yevgen Voronenko, Cody A Wages, Peter D ...> ;Frontiers in Oncology. 2022 Jan 1
• 3 citations
  NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model.
  Yun Hu, Sébastien Paris, Genevieve Bertolet, Hampartsoum B Barsoumian, Qi Wang, Jordan Da Silva, Nalini B Patel, Nguyen Nguyen, Denaha J Doss, Ailing Huang, Ethan Hsu,...> ;Frontiers in Immunology. 2022 Jan 1
• Join now to see all

Lectures

• Randomized phase I/II trial of pembrolizumab with and without radiotherapy for metastatic non-small cell lung cancer. 
  2019 ASCO Annual Meeting - 6/1/2019